<img alt="" src="https://secure.perk0mean.com/184504.png" style="display:none;">

Charting a Course Through Complexity in Clinical Trials - Part 1

About the Episode

In part 1 of this episode, Libbi and Siobhan delve into the escalating intricacies of clinical trials, shedding light on the challenges and solutions within the realm of Randomization and Trial Supply Management (RTSM) build for clinical trial protocols. As the pharmaceutical and biotech industries evolve, so does the demand for adaptive and nuanced approaches to address the growing complexity in trial designs.

The conversation unfolds as they explore the delicate nuances involved in tailoring the RTSM build directly to the specific needs of the protocol. Siobhan, drawing from her extensive experience, emphasizes the critical role of having a proficient team of RTSM experts. Together, they dissect the importance of this expertise in supporting end-users and, ultimately, ensuring the well-being of patients throughout the clinical trial journey.

See Who’s Talking

LIBBI RICKENBACHER

VP, Marketing and Partnerships

Libbi Rickenbacher, Vice President of Marketing and Partnerships at 4G Clinical, brings extensive industry experience across clinical research, commercial strategy, brand leadership, and partnership development. She leads global marketing and strategic partnership initiatives with a focus on positioning 4G Clinical for growth, strengthening market presence, and building meaningful industry collaboration. At 4G Clinical, Libbi is responsible for shaping brand strategy, advancing thought leadership, driving go-to-market execution, and developing partnerships that support innovation across the clinical trial ecosystem. Libbi holds a BA in psychology and neuroscience and a PhD in neuroscience.

SIOBHAN MCKENNA-POWER

Client Services Lead

Siobhan McKenna-Power has over 20 years of experience designing and delivering regulated systems, with over 8 years designing and delivering RTSM systems for clinical trials. Siobhan possesses a keen understanding of what the needs of the end user are and works to ensure that even the most complex trials are easy for Investigators to work with, and that patient safety is the foremost priority of any RTSM system.

Subscribe to our podcast